APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Atorvastatin Calcium

Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Atorvastatin calcium usually is white powder and whose CAS number is 134523-03-8.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Atorvastatin calcium usually is white powder and whose CAS number is 134523-03-8.

Selected research

Market Structure

Global Atorvastatin Calcium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173968010325 December 2025192 pages

Choose your research edition.

Industry ResearchAtorvastatin Calcium Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Atorvastatin Calcium Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Atorvastatin Calcium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Atorvastatin Calcium Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Atorvastatin Calcium Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Atorvastatin calcium usually is white powder and whose CAS number is 134523-03-8.

The key players of global Atorvastatin Calcium include Pfizer, DSM Sinochem Pharmaceuticals, Ind-Swift, Cadila Pharmaceuticals, Morepen and Sun Pharmaceutical Industries. Pfizer is the leader of this industry with about 26% market shares. India and China are the main consumption bases, and India holds 35% consumption share, and China holds 18% consumption share. They occupy 54% of the global consumption in total.

This report provides an overview of the global Atorvastatin Calcium market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Atorvastatin Calcium and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Atorvastatin Calcium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Atorvastatin Calcium market size, projected growth trends, production technologies, key applications, and end-use industries.

Atorvastatin Calcium Segment by Company

Pfizer

DSM Sinochem Pharmaceuticals

Ind-Swift

Cadila Pharmaceuticals

Morepen

Sun Pharmaceutical Industries

MSN Laboratories

Dr. Reddy's

Teva Pharmaceutical Industries

Apotex Pharmachem

Zheijang Neo-Dankon Pharmaceutical

Ningbo Menovo Pharmaceuticals Group

Jialin Pharmaceutical

Topfond

Zhejiang Hisun Pharmacutical

Zhejiang Hongyuan Pharmaceutical

Hubei Yitai Pharmaceutical

Jiangsu Hengrui Medicine

Atorvastatin Calcium Segment by Type

Chemical Synthesis

Biocatalysis

Atorvastatin Calcium Segment by Application

Tablet (Including Dispersible Tablet and General Tablet)

Capsule

Others

Atorvastatin Calcium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atorvastatin Calcium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Atorvastatin Calcium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atorvastatin Calcium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Atorvastatin Calcium market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Atorvastatin Calcium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Atorvastatin Calcium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Atorvastatin Calcium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Atorvastatin Calcium Industry Trends Table 2. Atorvastatin Calcium Industry Drivers Table 3. Atorvastatin Calcium Industry Opportunities and Challenges Table 4. Atorvastatin Calcium Industry Restraints Table 5. Global Atorvastatin Calcium Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Atorvastatin Calcium Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Atorvastatin Calcium Sales by Manufacturers (MT) & (2021-2026) Table 8. Global Atorvastatin Calcium Sales Market Share by Manufacturers Table 9. Global Atorvastatin Calcium Average Sales Price (K USD/MT) of Manufacturers (2021-2026) Table 10. Global Atorvastatin Calcium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Atorvastatin Calcium Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Atorvastatin Calcium Manufacturers, Product Type & Application Table 13. Global Atorvastatin Calcium Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Atorvastatin Calcium by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Chemical Synthesis Table 17. Major Manufacturers of Biocatalysis Table 18. Global Atorvastatin Calcium Sales by Type 2021 VS 2025 VS 2032 (MT) Table 19. Global Atorvastatin Calcium Sales by Type (2021-2026) & (MT) Table 20. Global Atorvastatin Calcium Sales by Type (2027-2032) & (MT) Table 21. Global Atorvastatin Calcium Sales Market Share by Type (2021-2026) Table 22. Global Atorvastatin Calcium Sales Market Share by Type (2027-2032) Table 23. Global Atorvastatin Calcium Revenue by Type 2021 VS 2025 VS 2032 (MT) Table 24. Global Atorvastatin Calcium Revenue by Type (2021-2026) & (MT) Table 25. Global Atorvastatin Calcium Revenue by Type (2027-2032) & (MT) Table 26. Global Atorvastatin Calcium Revenue Market Share by Type (2021-2026) Table 27. Global Atorvastatin Calcium Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Tablet (Including Dispersible Tablet and General Tablet) Table 29. Major Manufacturers of Capsule Table 30. Major Manufacturers of Others Table 31. Global Atorvastatin Calcium Sales by Application 2021 VS 2025 VS 2032 (MT) Table 32. Global Atorvastatin Calcium Sales by Application (2021-2026) & (MT) Table 33. Global Atorvastatin Calcium Sales by Application (2027-2032) & (MT) Table 34. Global Atorvastatin Calcium Sales Market Share by Application (2021-2026) Table 35. Global Atorvastatin Calcium Sales Market Share by Application (2027-2032) Table 36. Global Atorvastatin Calcium Revenue by Application 2021 VS 2025 VS 2032 (MT) Table 37. Global Atorvastatin Calcium Revenue by Application (2021-2026) & (MT) Table 38. Global Atorvastatin Calcium Revenue by Application (2027-2032) & (MT) Table 39. Global Atorvastatin Calcium Revenue Market Share by Application (2021-2026) Table 40. Global Atorvastatin Calcium Revenue Market Share by Application (2027-2032) Table 41. Global Atorvastatin Calcium Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 42. Global Atorvastatin Calcium Sales by Region (2021-2026) & (MT) Table 43. Global Atorvastatin Calcium Sales Market Share by Region (2021-2026) Table 44. Global Atorvastatin Calcium Sales Forecasted by Region (2027-2032) & (MT) Table 45. Global Atorvastatin Calcium Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Atorvastatin Calcium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 47. North America Atorvastatin Calcium Sales by Country (2021-2026) & (MT) Table 48. North America Atorvastatin Calcium Sales by Country (2027-2032) & (MT) Table 49. Europe Atorvastatin Calcium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 50. Europe Atorvastatin Calcium Sales by Country (2021-2026) & (MT) Table 51. Europe Atorvastatin Calcium Sales by Country (2027-2032) & (MT) Table 52. Asia Pacific Atorvastatin Calcium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 53. Asia Pacific Atorvastatin Calcium Sales by Country (2021-2026) & (MT) Table 54. Asia Pacific Atorvastatin Calcium Sales by Country (2027-2032) & (MT) Table 55. South America, Middle East and Africa Atorvastatin Calcium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 56. South America, Middle East and Africa Atorvastatin Calcium Sales by Country (2021-2026) & (MT) Table 57. South America, Middle East and Africa Atorvastatin Calcium Sales by Country (2027-2032) & (MT) Table 58. Global Atorvastatin Calcium Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Atorvastatin Calcium Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Atorvastatin Calcium Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Atorvastatin Calcium Revenue Market Share by Region (2021-2026) Table 62. Global Atorvastatin Calcium Revenue Market Share by Region (2027-2032) Table 63. Pfizer Company Information Table 64. Pfizer Business Overview Table 65. Pfizer Atorvastatin Calcium Sales (MT), Price (K USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Pfizer Atorvastatin Calcium Product Portfolio Table 67. Pfizer Recent Development Table 68. DSM Sinochem Pharmaceuticals Company Information Table 69. DSM Sinochem Pharmaceuticals Business Overview Table 70. DSM Sinochem Pharmaceuticals Atorvastatin Calcium Sales (MT), Price (K USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. DSM Sinochem Pharmaceuticals Atorvastatin Calcium Product Portfolio Table 72. DSM Sinochem Pharmaceuticals Recent Development Table 73. Ind-Swift Company Information Table 74. Ind-Swift Business Overview Table 75. Ind-Swift Atorvastatin Calcium Sales (MT), Price (K USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Ind-Swift Atorvastatin Calcium Product Portfolio Table 77. Ind-Swift Recent Development Table 78. Cadila Pharmaceuticals Company Information Table 79. Cadila Pharmaceuticals Business Overview Table 80. Cadila Pharmaceuticals Atorvastatin Calcium Sales (MT), Price (K USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Cadila Pharmaceuticals Atorvastatin Calcium Product Portfolio Table 82. Cadila Pharmaceuticals Recent Development Table 83. Morepen Company Information Table 84. Morepen Business Overview Table 85. Morepen Atorvastatin Calcium Sales (MT), Price (K USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Morepen Atorvastatin Calcium Product Portfolio Table 87. Morepen Recent Development Table 88. Sun Pharmaceutical Industries Company Information Table 89. Sun Pharmaceutical Industries Business Overview Table 90. Sun Pharmaceutical Industries Atorvastatin Calcium Sales (MT), Price (K USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Sun Pharmaceutical Industries Atorvastatin Calcium Product Portfolio Table 92. Sun Pharmaceutical Industries Recent Development Table 93. MSN Laboratories Company Information Table 94. MSN Laboratories Business Overview Table 95. MSN Laboratories Atorvastatin Calcium Sales (MT), Price (K USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. MSN Laboratories Atorvastatin Calcium Product Portfolio Table 97. MSN Laboratories Recent Development Table 98. Dr. Reddy's Company Information Table 99. Dr. Reddy's Business Overview Table 100. Dr. Reddy's Atorvastatin Calcium Sales (MT), Price (K USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Dr. Reddy's Atorvastatin Calcium Product Portfolio Table 102. Dr. Reddy's Recent Development Table 103. Teva Pharmaceutical Industries Company Information Table 104. Teva Pharmaceutical Industries Business Overview Table 105. Teva Pharmaceutical Industries Atorvastatin Calcium Sales (MT), Price (K USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Teva Pharmaceutical Industries Atorvastatin Calcium Product Portfolio Table 107. Teva Pharmaceutical Industries Recent Development Table 108. Apotex Pharmachem Company Information Table 109. Apotex Pharmachem Business Overview Table 110. Apotex Pharmachem Atorvastatin Calcium Sales (MT), Price (K USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Apotex Pharmachem Atorvastatin Calcium Product Portfolio Table 112. Apotex Pharmachem Recent Development Table 113. Zheijang Neo-Dankon Pharmaceutical Company Information Table 114. Zheijang Neo-Dankon Pharmaceutical Business Overview Table 115. Zheijang Neo-Dankon Pharmaceutical Atorvastatin Calcium Sales (MT), Price (K USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Zheijang Neo-Dankon Pharmaceutical Atorvastatin Calcium Product Portfolio Table 117. Zheijang Neo-Dankon Pharmaceutical Recent Development Table 118. Ningbo Menovo Pharmaceuticals Group Company Information Table 119. Ningbo Menovo Pharmaceuticals Group Business Overview Table 120. Ningbo Menovo Pharmaceuticals Group Atorvastatin Calcium Sales (MT), Price (K USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Ningbo Menovo Pharmaceuticals Group Atorvastatin Calcium Product Portfolio Table 122. Ningbo Menovo Pharmaceuticals Group Recent Development Table 123. Jialin Pharmaceutical Company Information Table 124. Jialin Pharmaceutical Business Overview Table 125. Jialin Pharmaceutical Atorvastatin Calcium Sales (MT), Price (K USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Jialin Pharmaceutical Atorvastatin Calcium Product Portfolio Table 127. Jialin Pharmaceutical Recent Development Table 128. Topfond Company Information Table 129. Topfond Business Overview Table 130. Topfond Atorvastatin Calcium Sales (MT), Price (K USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Topfond Atorvastatin Calcium Product Portfolio Table 132. Topfond Recent Development Table 133. Zhejiang Hisun Pharmacutical Company Information Table 134. Zhejiang Hisun Pharmacutical Business Overview Table 135. Zhejiang Hisun Pharmacutical Atorvastatin Calcium Sales (MT), Price (K USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Zhejiang Hisun Pharmacutical Atorvastatin Calcium Product Portfolio Table 137. Zhejiang Hisun Pharmacutical Recent Development Table 138. Zhejiang Hongyuan Pharmaceutical Company Information Table 139. Zhejiang Hongyuan Pharmaceutical Business Overview Table 140. Zhejiang Hongyuan Pharmaceutical Atorvastatin Calcium Sales (MT), Price (K USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Zhejiang Hongyuan Pharmaceutical Atorvastatin Calcium Product Portfolio Table 142. Zhejiang Hongyuan Pharmaceutical Recent Development Table 143. Hubei Yitai Pharmaceutical Company Information Table 144. Hubei Yitai Pharmaceutical Business Overview Table 145. Hubei Yitai Pharmaceutical Atorvastatin Calcium Sales (MT), Price (K USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Hubei Yitai Pharmaceutical Atorvastatin Calcium Product Portfolio Table 147. Hubei Yitai Pharmaceutical Recent Development Table 148. Jiangsu Hengrui Medicine Company Information Table 149. Jiangsu Hengrui Medicine Business Overview Table 150. Jiangsu Hengrui Medicine Atorvastatin Calcium Sales (MT), Price (K USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Jiangsu Hengrui Medicine Atorvastatin Calcium Product Portfolio Table 152. Jiangsu Hengrui Medicine Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Atorvastatin Calcium Distributors List Table 156. Atorvastatin Calcium Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Atorvastatin Calcium Product Image Figure 2. Global Atorvastatin Calcium Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Atorvastatin Calcium Market Size (2021-2032) & (US$ Million) Figure 4. Global Atorvastatin Calcium Sales (2021-2032) & (MT) Figure 5. Global Atorvastatin Calcium Average Price (K USD/MT) & (2021-2032) Figure 6. Global Top 5 and 10 Atorvastatin Calcium Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Chemical Synthesis Image Figure 9. Biocatalysis Image Figure 10. Global Atorvastatin Calcium Sales by Type (2021 VS 2025 VS 2032) & (MT) Figure 11. Global Atorvastatin Calcium Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Atorvastatin Calcium Sales Market Share by Type (2021-2032) Figure 13. Global Atorvastatin Calcium Revenue by Type (2021 VS 2025 VS 2032) & (MT) Figure 14. Global Atorvastatin Calcium Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Atorvastatin Calcium Revenue Market Share by Type (2021-2032) Figure 16. Tablet (Including Dispersible Tablet and General Tablet) Image Figure 17. Capsule Image Figure 18. Others Image Figure 19. Global Atorvastatin Calcium Sales by Application (2021 VS 2025 VS 2032) & (MT) Figure 20. Global Atorvastatin Calcium Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Atorvastatin Calcium Sales Market Share by Application (2021-2032) Figure 22. Global Atorvastatin Calcium Revenue by Application (2021 VS 2025 VS 2032) & (MT) Figure 23. Global Atorvastatin Calcium Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Atorvastatin Calcium Revenue Market Share by Application (2021-2032) Figure 25. North America Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 26. North America Atorvastatin Calcium Sales Market Share by Country (2021-2032) Figure 27. U.S. Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 28. Canada Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 29. Mexico Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 30. Europe Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 31. Europe Atorvastatin Calcium Sales Market Share by Country (2021-2032) Figure 32. Germany Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 33. France Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 34. U.K. Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 35. Italy Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 36. Netherlands Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 37. Asia Pacific Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 38. Asia Pacific Atorvastatin Calcium Sales Market Share by Country (2021-2032) Figure 39. China Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 40. Japan Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 41. South Korea Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 42. Southeast Asia Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 43. India Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 44. Australia Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 45. South America, Middle East and Africa Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 46. South America, Middle East and Africa Atorvastatin Calcium Sales Market Share by Country (2021-2032) Figure 47. Brazil Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 48. South Africa Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 49. Saudi Arabia Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 50. Turkey Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 51. Argentina Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 52. UAE Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 53. Egypt Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 54. Chile Atorvastatin Calcium Sales and Growth Rate (2021-2032) & (MT) Figure 55. Global Atorvastatin Calcium Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Atorvastatin Calcium Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Atorvastatin Calcium Revenue (2021-2032) & (US$ Million) Figure 58. North America Atorvastatin Calcium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Atorvastatin Calcium Revenue (2021-2032) & (US$ Million) Figure 60. Europe Atorvastatin Calcium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Atorvastatin Calcium Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Atorvastatin Calcium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Atorvastatin Calcium Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Atorvastatin Calcium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Atorvastatin Calcium Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Atorvastatin Calcium Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Chemical Synthesis
  • Biocatalysis
Applications
  • Tablet (Including Dispersible Tablet and General Tablet)
  • Capsule
  • Others
Companies covered
  • Pfizer
  • DSM Sinochem Pharmaceuticals
  • Ind-Swift
  • Cadila Pharmaceuticals
  • Morepen
  • Sun Pharmaceutical Industries
  • MSN Laboratories
  • Dr. Reddy's
  • Teva Pharmaceutical Industries
  • Apotex Pharmachem
  • Zheijang Neo-Dankon Pharmaceutical
  • Ningbo Menovo Pharmaceuticals Group
  • Jialin Pharmaceutical
  • Topfond
  • Zhejiang Hisun Pharmacutical
  • Zhejiang Hongyuan Pharmaceutical
  • Hubei Yitai Pharmaceutical
  • Jiangsu Hengrui Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Atorvastatin Calcium Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Atorvastatin Calcium Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Atorvastatin Calcium Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Atorvastatin Calcium Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Atorvastatin Calcium Market Dynamics
  1. 2.1 Atorvastatin Calcium Industry Trends
  2. 2.2 Atorvastatin Calcium Industry Drivers
  3. 2.3 Atorvastatin Calcium Industry Opportunities and Challenges
  4. 2.4 Atorvastatin Calcium Industry Restraints
3 Atorvastatin Calcium Market by Manufacturers
  1. 3.1 Global Atorvastatin Calcium Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Atorvastatin Calcium Sales by Manufacturers (2021-2026)
  3. 3.3 Global Atorvastatin Calcium Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Atorvastatin Calcium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Atorvastatin Calcium Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Atorvastatin Calcium Manufacturers, Product Type & Application
  7. 3.7 Global Atorvastatin Calcium Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Atorvastatin Calcium Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Atorvastatin Calcium Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Atorvastatin Calcium Tier 1, Tier 2, and Tier 3
4 Atorvastatin Calcium Market by Type
  1. 4.1 Atorvastatin Calcium Type Introduction
  2. 4.1.1 Chemical Synthesis
  3. 4.1.2 Biocatalysis
  4. 4.2 Global Atorvastatin Calcium Sales by Type
  5. 4.2.1 Global Atorvastatin Calcium Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Atorvastatin Calcium Sales by Type (2021-2032)
  7. 4.2.3 Global Atorvastatin Calcium Sales Market Share by Type (2021-2032)
  8. 4.3 Global Atorvastatin Calcium Revenue by Type
  9. 4.3.1 Global Atorvastatin Calcium Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Atorvastatin Calcium Revenue by Type (2021-2032)
  11. 4.3.3 Global Atorvastatin Calcium Revenue Market Share by Type (2021-2032)
5 Atorvastatin Calcium Market by Application
  1. 5.1 Atorvastatin Calcium Application Introduction
  2. 5.1.1 Tablet (Including Dispersible Tablet and General Tablet)
  3. 5.1.2 Capsule
  4. 5.1.3 Others
  5. 5.2 Global Atorvastatin Calcium Sales by Application
  6. 5.2.1 Global Atorvastatin Calcium Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Atorvastatin Calcium Sales by Application (2021-2032)
  8. 5.2.3 Global Atorvastatin Calcium Sales Market Share by Application (2021-2032)
  9. 5.3 Global Atorvastatin Calcium Revenue by Application
  10. 5.3.1 Global Atorvastatin Calcium Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Atorvastatin Calcium Revenue by Application (2021-2032)
  12. 5.3.3 Global Atorvastatin Calcium Revenue Market Share by Application (2021-2032)
6 Global Atorvastatin Calcium Sales by Region
  1. 6.1 Global Atorvastatin Calcium Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Atorvastatin Calcium Sales by Region (2021-2032)
  3. 6.2.1 Global Atorvastatin Calcium Sales by Region (2021-2026)
  4. 6.2.2 Global Atorvastatin Calcium Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Atorvastatin Calcium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Atorvastatin Calcium Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Atorvastatin Calcium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Atorvastatin Calcium Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Atorvastatin Calcium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Atorvastatin Calcium Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Atorvastatin Calcium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Atorvastatin Calcium Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Atorvastatin Calcium Revenue by Region
  1. 7.1 Global Atorvastatin Calcium Revenue by Region
  2. 7.1.1 Global Atorvastatin Calcium Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Atorvastatin Calcium Revenue by Region (2021-2026)
  4. 7.1.3 Global Atorvastatin Calcium Revenue by Region (2027-2032)
  5. 7.1.4 Global Atorvastatin Calcium Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Atorvastatin Calcium Revenue (2021-2032)
  8. 7.2.2 North America Atorvastatin Calcium Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Atorvastatin Calcium Revenue (2021-2032)
  11. 7.3.2 Europe Atorvastatin Calcium Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Atorvastatin Calcium Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Atorvastatin Calcium Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Atorvastatin Calcium Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Atorvastatin Calcium Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Pfizer
  2. 8.1.1 Pfizer Company Information
  3. 8.1.2 Pfizer Business Overview
  4. 8.1.3 Pfizer Atorvastatin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Pfizer Atorvastatin Calcium Product Portfolio
  6. 8.1.5 Pfizer Recent Developments
  7. 8.2 DSM Sinochem Pharmaceuticals
  8. 8.2.1 DSM Sinochem Pharmaceuticals Company Information
  9. 8.2.2 DSM Sinochem Pharmaceuticals Business Overview
  10. 8.2.3 DSM Sinochem Pharmaceuticals Atorvastatin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 DSM Sinochem Pharmaceuticals Atorvastatin Calcium Product Portfolio
  12. 8.2.5 DSM Sinochem Pharmaceuticals Recent Developments
  13. 8.3 Ind-Swift
  14. 8.3.1 Ind-Swift Company Information
  15. 8.3.2 Ind-Swift Business Overview
  16. 8.3.3 Ind-Swift Atorvastatin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ind-Swift Atorvastatin Calcium Product Portfolio
  18. 8.3.5 Ind-Swift Recent Developments
  19. 8.4 Cadila Pharmaceuticals
  20. 8.4.1 Cadila Pharmaceuticals Company Information
  21. 8.4.2 Cadila Pharmaceuticals Business Overview
  22. 8.4.3 Cadila Pharmaceuticals Atorvastatin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Cadila Pharmaceuticals Atorvastatin Calcium Product Portfolio
  24. 8.4.5 Cadila Pharmaceuticals Recent Developments
  25. 8.5 Morepen
  26. 8.5.1 Morepen Company Information
  27. 8.5.2 Morepen Business Overview
  28. 8.5.3 Morepen Atorvastatin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Morepen Atorvastatin Calcium Product Portfolio
  30. 8.5.5 Morepen Recent Developments
  31. 8.6 Sun Pharmaceutical Industries
  32. 8.6.1 Sun Pharmaceutical Industries Company Information
  33. 8.6.2 Sun Pharmaceutical Industries Business Overview
  34. 8.6.3 Sun Pharmaceutical Industries Atorvastatin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sun Pharmaceutical Industries Atorvastatin Calcium Product Portfolio
  36. 8.6.5 Sun Pharmaceutical Industries Recent Developments
  37. 8.7 MSN Laboratories
  38. 8.7.1 MSN Laboratories Company Information
  39. 8.7.2 MSN Laboratories Business Overview
  40. 8.7.3 MSN Laboratories Atorvastatin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 MSN Laboratories Atorvastatin Calcium Product Portfolio
  42. 8.7.5 MSN Laboratories Recent Developments
  43. 8.8 Dr. Reddy's
  44. 8.8.1 Dr. Reddy's Company Information
  45. 8.8.2 Dr. Reddy's Business Overview
  46. 8.8.3 Dr. Reddy's Atorvastatin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Dr. Reddy's Atorvastatin Calcium Product Portfolio
  48. 8.8.5 Dr. Reddy's Recent Developments
  49. 8.9 Teva Pharmaceutical Industries
  50. 8.9.1 Teva Pharmaceutical Industries Company Information
  51. 8.9.2 Teva Pharmaceutical Industries Business Overview
  52. 8.9.3 Teva Pharmaceutical Industries Atorvastatin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Teva Pharmaceutical Industries Atorvastatin Calcium Product Portfolio
  54. 8.9.5 Teva Pharmaceutical Industries Recent Developments
  55. 8.10 Apotex Pharmachem
  56. 8.10.1 Apotex Pharmachem Company Information
  57. 8.10.2 Apotex Pharmachem Business Overview
  58. 8.10.3 Apotex Pharmachem Atorvastatin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Apotex Pharmachem Atorvastatin Calcium Product Portfolio
  60. 8.10.5 Apotex Pharmachem Recent Developments
  61. 8.11 Zheijang Neo-Dankon Pharmaceutical
  62. 8.11.1 Zheijang Neo-Dankon Pharmaceutical Company Information
  63. 8.11.2 Zheijang Neo-Dankon Pharmaceutical Business Overview
  64. 8.11.3 Zheijang Neo-Dankon Pharmaceutical Atorvastatin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Zheijang Neo-Dankon Pharmaceutical Atorvastatin Calcium Product Portfolio
  66. 8.11.5 Zheijang Neo-Dankon Pharmaceutical Recent Developments
  67. 8.12 Ningbo Menovo Pharmaceuticals Group
  68. 8.12.1 Ningbo Menovo Pharmaceuticals Group Company Information
  69. 8.12.2 Ningbo Menovo Pharmaceuticals Group Business Overview
  70. 8.12.3 Ningbo Menovo Pharmaceuticals Group Atorvastatin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Ningbo Menovo Pharmaceuticals Group Atorvastatin Calcium Product Portfolio
  72. 8.12.5 Ningbo Menovo Pharmaceuticals Group Recent Developments
  73. 8.13 Jialin Pharmaceutical
  74. 8.13.1 Jialin Pharmaceutical Company Information
  75. 8.13.2 Jialin Pharmaceutical Business Overview
  76. 8.13.3 Jialin Pharmaceutical Atorvastatin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Jialin Pharmaceutical Atorvastatin Calcium Product Portfolio
  78. 8.13.5 Jialin Pharmaceutical Recent Developments
  79. 8.14 Topfond
  80. 8.14.1 Topfond Company Information
  81. 8.14.2 Topfond Business Overview
  82. 8.14.3 Topfond Atorvastatin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Topfond Atorvastatin Calcium Product Portfolio
  84. 8.14.5 Topfond Recent Developments
  85. 8.15 Zhejiang Hisun Pharmacutical
  86. 8.15.1 Zhejiang Hisun Pharmacutical Company Information
  87. 8.15.2 Zhejiang Hisun Pharmacutical Business Overview
  88. 8.15.3 Zhejiang Hisun Pharmacutical Atorvastatin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Zhejiang Hisun Pharmacutical Atorvastatin Calcium Product Portfolio
  90. 8.15.5 Zhejiang Hisun Pharmacutical Recent Developments
  91. 8.16 Zhejiang Hongyuan Pharmaceutical
  92. 8.16.1 Zhejiang Hongyuan Pharmaceutical Company Information
  93. 8.16.2 Zhejiang Hongyuan Pharmaceutical Business Overview
  94. 8.16.3 Zhejiang Hongyuan Pharmaceutical Atorvastatin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Zhejiang Hongyuan Pharmaceutical Atorvastatin Calcium Product Portfolio
  96. 8.16.5 Zhejiang Hongyuan Pharmaceutical Recent Developments
  97. 8.17 Hubei Yitai Pharmaceutical
  98. 8.17.1 Hubei Yitai Pharmaceutical Company Information
  99. 8.17.2 Hubei Yitai Pharmaceutical Business Overview
  100. 8.17.3 Hubei Yitai Pharmaceutical Atorvastatin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Hubei Yitai Pharmaceutical Atorvastatin Calcium Product Portfolio
  102. 8.17.5 Hubei Yitai Pharmaceutical Recent Developments
  103. 8.18 Jiangsu Hengrui Medicine
  104. 8.18.1 Jiangsu Hengrui Medicine Company Information
  105. 8.18.2 Jiangsu Hengrui Medicine Business Overview
  106. 8.18.3 Jiangsu Hengrui Medicine Atorvastatin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Jiangsu Hengrui Medicine Atorvastatin Calcium Product Portfolio
  108. 8.18.5 Jiangsu Hengrui Medicine Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Atorvastatin Calcium Value Chain Analysis
  2. 9.1.1 Atorvastatin Calcium Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Atorvastatin Calcium Production Mode & Process
  6. 9.2 Atorvastatin Calcium Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Atorvastatin Calcium Distributors
  9. 9.2.3 Atorvastatin Calcium Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst